Get started
Author

Ratnakar Pingili

Observed names: Pingili, Ratnakar, R. Pingili
ORCID: 0000-0002-4553-1871
Observed ORCID: 0000-0002-4553-1871
OpenAlex ID: A5089098765
Ofatumumab versus Teriflunomide in Multiple Sclerosis
2020 · Stephen L. Hauser, Amit Bar-Or, et al. · New England Journal of Medicine · 743
PDF
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
2022 · Jutta Gärtner, Stephen L Hauser, et al. · Multiple Sclerosis Journal · 112
PDF
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years
2022 · Stephen L Hauser, Anne H Cross, et al. · Multiple Sclerosis Journal · 83
Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis
2022 · Huixin Yu, Gordon Graham, et al. · CNS Drugs · 43
PDF
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study
2021 · Jun-ichi Kira, Jin Nakahara, et al. · Multiple Sclerosis Journal · 33
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
2022 · Anne H. Cross, Silvia Delgado, et al. · Neurology and Therapy · 28
PDF
Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300)
2021 · Amit Bar-Or, Jerome De Seze, et al. · Neurology · 11
Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys
2021 · Muriel Bellot, C. Marc Luetjens, et al. · Reproductive Toxicology · 7
PDF
Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab
2022 · Bassem Yamout, Kerstin Hellwig, et al. · Multiple Sclerosis and Related Disorders · 6
Long-term Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (S14.004)
2022 · Stephen L. Hauser, Anne H. Cross, et al. · Neurology · 5
Characteristics and Outcome of COVID-19 in Patients with Relapsing Multiple Sclerosis Receiving Ofatumumab (4123)
2021 · Anne H. Cross, Silvia Delgado, et al. · Neurology · 5
Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab (P4-4.007)
2022 · Kerstin Hellwig, Bassem Yamout, et al. · Neurology · 3
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
2022 · Anne H. Cross, Silvia Delgado, et al. · Neurology and Therapy · 2
PDF
2323 Injection-related reactions with subcutaneous administration of ofatumumab in relapsing multiple sclerosis: data from clinical studies and post marketing experience
2022 · John Parratt, John Kramer, et al. · BMJ Neurology Open · 1
PDF
Injection-Related Reactions with Subcutaneous Administration of Ofatumumab in Relapsing Multiple Sclerosis: Data from Clinical Studies and Post Marketing Experience (P7-4.011)
2022 · John Kramer, Ratnakar Pingili, et al. · Neurology · 1
Effect of Ofatumumab on Pregnancy, Parturition and Lactation in Cynomolgus Monkeys (2265)
2021 · Muriel Bellot, Morten Bagger, et al. · Neurology · 1
P287 Idiopathic rupture of the foetal bladder during labour
2009 · R. Pingili, S. Vitthala, et al. · International Journal of Gynecology & Obstetrics · 1
117 Sustained and rapid B-cell depletion with ofatumumab: population pharma- cokinetic B-cell modeling in relapsing MS patients
2022 · Gordon Graham, Joseph Kahn, et al. · Journal of Neurology Neurosurgery & Psychiatry
Comparative Safety Assessment of Ofatumumab using Data from ASCLEPIOS I/II versus a Historical Propensity-adjusted Placebo Arm (2221)
2021 · Ayan Das Gupta, Ratnakar Pingili, et al. · Neurology
Sustained Efficacy of Ofatumumab in Relapsing Multiple Sclerosis Patients: Results from Extended Treatment in the Phase 2 APOLITOS Study (2032)
2021 · Takahiko Saida, Jin Nakahara, et al. · Neurology
O979 Effect of hormone therapy (HT) on normal uterine & endometrial development in women with premature ovarian failure (POF): A systematic review
2009 · S. Vitthala, T. Gelbaya, et al. · International Journal of Gynecology & Obstetrics
Works count: 38
Citation count: 1,085
H-index: 7
I10-index: 7
Year
Topic
Type